Compare ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund vs Mirae Asset Healthcare Fund
Risk
Very High
Very High
Rating
5.0
3.0
Min SIP Amount
₹100
₹99
Expense Ratio
1.99
2.03
NAV
₹38.69
₹39.21
Fund Started
25 Jun 2018
11 Jun 2018
Fund Size
₹6293.14 Cr
₹2753.72 Cr
Exit Load
Exit load of 1% if redeemed within 15 days.
Exit load of 1% if redeemed within 1 year.
1 Year
4.37%
6.64%
3 Year
25.91%
23.24%
5 Year
15.56%
14.11%
Equity
97.62%
99.92%
Cash
2.35%
0.08%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Divi's Laboratories Ltd. | 7.93% |
Glenmark Pharmaceuticals Ltd. | 6.94% |
JB Chemicals & Pharmaceuticals Ltd. | 6.88% |
Apollo Hospitals Enterprise Ltd. | 6.15% |
Lupin Ltd. | 5.06% |
Aurobindo Pharma Ltd. | 4.32% |
Dr. Reddy's Laboratories Ltd. | 4.31% |
Fortis Healthcare Ltd. | 3.73% |
Laurus Labs Ltd. | 3.56% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Launch Date
25 Jun 2018
11 Jun 2018
